TMCI Earnings & Financial Statements
Treace Medical Concepts, Inc.
$4.21
+$0.17(+4.08%)
43
Overall
60
Value
30
Tech
39
Quality
Market Cap
$266.64M
Volume
70.12K
52W Range
$1.17 - $7.08
Target Price
$5.50
TMCI earnings and financial statements: Treace Medical Concepts, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
TMCI Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $212.69M | $209.36M | $187.12M | $141.84M | $94.42M |
| Cost of revenue | $42.94M | $41.09M | $35.18M | $25.53M | $17.83M |
| Operating income | -$54.15M | -$55.69M | -$51.43M | -$34.84M | -$16.51M |
| EBITDA | -$42.77M | -$41.77M | -$38.71M | -$36.04M | -$15.61M |
| Net income | -$59.00M | -$55.74M | -$49.53M | -$42.81M | -$20.55M |
| EPS (diluted) | $-0.93 | $-0.90 | $-0.81 | $-0.77 | $-0.43 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $190.58M | $217.09M | $251.91M | $159.02M | $140.82M |
| Total liabilities | $103.25M | $104.20M | $113.97M | $98.50M | $47.75M |
| Shareholders’ equity | $87.33M | $112.89M | $137.94M | $60.53M | $93.07M |
| Cash and equivalents | $10.71M | $11.35M | $12.98M | $19.47M | $105.83M |
| Long-term debt | $69.56M | $69.24M | $68.90M | $68.25M | $29.36M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$15.97M | -$37.17M | -$34.58M | -$30.65M | -$17.19M |
| Capital expenditure | -$13.52M | -$11.59M | -$11.46M | -$14.84M | -$2.71M |
| Free cash flow | -$29.49M | -$48.76M | -$46.03M | -$45.49M | -$19.90M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TMCI | $4.21 | +4.1% | 70.12K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Treace Medical Concepts, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW